A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss

Anne G. M. Schilder, Stephan Wolpert, Shakeel Saeed, Leonie M. Middelink, Albert S. B. Edge, Helen Blackshaw, Unknown, Anne Schilder, Leonie Middelink, Albert Edge, Athanasios Bibas, Elizabeth Arram, Asger Bilhet, Hannah Cooper, Ernst Dalhoff, Femke van Diggelen, Rolf Jan Rutten, Helmuth van Es, Karin Hojgaard, Eleftheria Iliadou, Omursen Yildirim, Sherif Khalil, Dimitris Kikidis, Hubert Lowenheim, Nikos Markatos, Marcus Mueller, Thore Schade-Mann, Fritz Schneider, Katerina Vardonikolaki, August Wilke, Kostas Pastiadis, Athanasios G. Bibas

Open source

DOI: 10.1038/s41467-024-45784-0
Published: 2024-03-01
Container: Nature Communications
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-024-45784-0,
  title = {A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss},
  author = {Anne G. M. Schilder and Stephan Wolpert and Shakeel Saeed and Leonie M. Middelink and Albert S. B. Edge and Helen Blackshaw and Unknown and Anne Schilder and Leonie Middelink and Albert Edge and Athanasios Bibas and Elizabeth Arram and Asger Bilhet and Hannah Cooper and Ernst Dalhoff and Femke van Diggelen and Rolf Jan Rutten and Helmuth van Es and Karin Hojgaard and Eleftheria Iliadou and Omursen Yildirim and Sherif Khalil and Dimitris Kikidis and Hubert Lowenheim and Nikos Markatos and Marcus Mueller and Thore Schade-Mann and Fritz Schneider and Katerina Vardonikolaki and August Wilke and Kostas Pastiadis and Athanasios G. Bibas},
  year = {2024},
  journal = {Nature Communications},
  doi = {10.1038/s41467-024-45784-0},
  url = {https://doi.org/10.1038/s41467-024-45784-0}
}

RIS

TY  - JOUR
TI  - A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss
AU  - Anne G. M. Schilder
AU  - Stephan Wolpert
AU  - Shakeel Saeed
AU  - Leonie M. Middelink
AU  - Albert S. B. Edge
AU  - Helen Blackshaw
AU  - Unknown
AU  - Anne Schilder
AU  - Leonie Middelink
AU  - Albert Edge
AU  - Athanasios Bibas
AU  - Elizabeth Arram
AU  - Asger Bilhet
AU  - Hannah Cooper
AU  - Ernst Dalhoff
AU  - Femke van Diggelen
AU  - Rolf Jan Rutten
AU  - Helmuth van Es
AU  - Karin Hojgaard
AU  - Eleftheria Iliadou
AU  - Omursen Yildirim
AU  - Sherif Khalil
AU  - Dimitris Kikidis
AU  - Hubert Lowenheim
AU  - Nikos Markatos
AU  - Marcus Mueller
AU  - Thore Schade-Mann
AU  - Fritz Schneider
AU  - Katerina Vardonikolaki
AU  - August Wilke
AU  - Kostas Pastiadis
AU  - Athanasios G. Bibas
PY  - 2024
JO  - Nature Communications
DO  - 10.1038/s41467-024-45784-0
UR  - https://doi.org/10.1038/s41467-024-45784-0
ER  -

APA

Schilder, A. G. M., Wolpert, S., Saeed, S., Middelink, L. M., Edge, A. S. B., Blackshaw, H., Unknown, Schilder, A., Middelink, L., Edge, A., Bibas, A., Arram, E., Bilhet, A., Cooper, H., Dalhoff, E., Diggelen, F. V., Rutten, R. J., Es, H. V., Hojgaard, K., Iliadou, E., Yildirim, O., Khalil, S., Kikidis, D., Lowenheim, H., Markatos, N., Mueller, M., Schade-Mann, T., Schneider, F., Vardonikolaki, K., Wilke, A., Pastiadis, K., & Bibas, A. G. (2024). A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss. Nature Communications. https://doi.org/10.1038/s41467-024-45784-0

Source records

crossref · retrieved 2026-11-10T20:42:34.744Z